Table 5.
Lesion analysis in patients in which all four imaging modalities were performed displaying detection rates and confidence intervals in total SDHA lesions, primary SDHA lesions, and metastatic SDHA lesions.
| 68Ga-DOTATATE | 18F-FDG | 18F-FDOPA | CT/MRI | |
|---|---|---|---|---|
| Total Lesions | 80/102 78.4 (69.2–90.0) |
81/102 79.4 (70.3–86.8) |
39/102 39.8 (30.2–50.2) |
55/102 53.9 (43.8–63.8) |
| Primary Lesions | 6/7 85.7 (42.1–99.6) |
6/7 85.7 (42.1–99.6) |
3/7 42.9 (9.9–81.6) |
6/7 85.7 (42.1–99.6) |
| Metastatic Lesions | 74/95 77.9 (68.2–85.8) |
75/95 79.0 (69.4–86.6) |
36/95 37.9 (28.1–48.4) |
49/95 51.6 (41.1–62.0) |